Zaniolo, O., Bamfi, F., & Iannazzo, S. (2007). Budget impact of rosiglitazone in type 2 diabetes. Farmeconomia. Health Economics and Therapeutic Pathways, 8(1), 15–26. https://doi.org/10.7175/fe.v8i1.252